Edição |
Seção |
Título |
Arquivo |
Nº 4-1 (2012) |
Articles |
USE OF PREIMPLANTATION DIAGNOSIS WITHIN THE FRAMEWORK OF AN ASSISTED REPRODUCTIVE TECHNOLOGY PROGRAM FOR MARRIED COUPLES WITH A COMBINATION OF MUTATIONS AT THE AZF LOCUS OF THE Y CHROMOSOME AND CFTR GENE POLYMORPHISM IN HUSBANDS |
|
Nº 4-2 (2012) |
Articles |
A RELATIONSHIP OF THE RESULTS OF SUPEROVULATION INDUCTION AND THE NUMBER OF EMBRYOS OBTAINED WITHIN AN IN VITRO FERTILIZATION PROGRAM TO THE TYPE OF CHROMOSOME ABERRATION IN THE KARYOTYPE OF A PATIENT |
|
Nº 4-2 (2012) |
Articles |
ROLE OF GENETIC AND AUTOIMMUNE DISORDERS IN THE DEVELOPMENT OF PREMATURE OVARIAN FAILURE |
|
Nº 6 (2012) |
Articles |
PERINATAL MORTALITY IN THE RUSSIAN FEDERATION: POSSIBLE WAYS OF ITS REDUCTION |
|
Nº 7 (2012) |
Articles |
RISK OF ANEUPLOIDY IN EMBRYOS OF MEN WITH PATHOZOOSPERMIA IN ASSISTED REPRODUCTIVE TECHNOLOGY PRACTICE (META-ANALYSIS) |
|
Nº 2 (2013) |
Articles |
EFFECT OF ANTHROPOGENIC CHEMICALS ON THE COURSE OF PREGNANCY |
|
Nº 3 (2013) |
Articles |
RELATIONSHIP OF PATHOZOOSPERMIA AND CHROMOSOME ANEUPLOIDY IN THE SPERM AND EMBRYOS IN ASSISTED REPRODUCTIVE TECHNOLOGY PROGRAMS |
|
Nº 5 (2013) |
Articles |
National maternal and child health care policy: Long-term development prospects |
|
Nº 9 (2013) |
Articles |
POOR OVARIAN RESPONSE IN IVF PROGRAMS |
|
Nº 12 (2013) |
Articles |
EFFECT OF ANTHROPOGENIC CHEMICAL SUBSTANCES ON NEONATAL WEIGHT |
|
Nº 3 (2016) |
Articles |
ESTIMATION OF CYTOKINE GENE EXPRESSION AND POLYMORPHISM AS PREDICTORS FOR CHRONIC ALLERGIC VULVOVAGINITIS |
|
Nº 10 (2019) |
Articles |
Receptivity of thin endometrium in patients undergoing assisted reproduction |
|
Nº 4 (2020) |
Articles |
The legal status of human embryo/fetus |
|
Nº 4 (2020) |
Articles |
Obstetric and neonatal outcomes of assisted reproductive technology programs using donor oocytes |
|
Nº 4 (2020) |
Articles |
Outcomes of assisted reproductive technologies in patients with persistence оf antiphospholipid antibodies |
|
Nº 5 (2021) |
Articles |
Bisphenol A in infertile patients: impact on assisted reproductive technologies outcomes |
|